Blackhawk growth corp

Blackhawk and MindBio Complete Plan Of Arrangement, Shares Spinout Investment holding company Blackhawk Growth Corp. and its psychedelics biotech subsidiary MindBio Therapeutics Corp. have completed the announced plan for the spinout of MindBio common shares. Blackhawk has renamed its common shares...

The psychedelics space is up and running. Together with the start of the new year, two companies have shared their latest financial decisions toward advancing their medical business programs. Blackhawk’s New Arrangement Plan For Three Of Its Businesses Investment holding company Blackhawk...

Mindbio Therapeutics, a company of the Blackhawk Growth Corp. (OTCPK: BLRZF) announced the completion of the world’s largest Phase 1 clinical trial for LSD microdosing. The randomized, double-blind placebo-controlled clinical trial lasted 12 months and included 80 healthy participants....